GLP-1 receptor agonists carry a boxed warning
Rajatanavin N, Suwanachote S, Kulkollakarn S
Although advertisements promote the drug as safe and effective, with few serious health risks, Renteria and a growing number of other former users are now pursuing Ozempic lawsuits and Wegovy lawsuits against Novo Nordisk, each raising similar allegations that a large number of users are experiencing long-term side effects, including gallbladder injuries, intestinal blockages, stomach paralysis and other injuries
In this Review, we outline the rationale for senescent cells as a therapeutic target for disorders across the lifespan and discuss the most promising strategiesincluding recent and ongoing clinical trialsfor translating small-molecule senolytics and other senescence-targeting interventions into clinical use
Here at Real Peptides, our team has spent years not just synthesizing high-purity peptides, but also consulting with researchers on the protocols that ensure those peptides yield clean, repeatable data